Biomarkers of islet beta cell stress and death in type 1 diabetes

Emily K. Sims, Carmella Evans-Molina, Sarah A. Tersey, Decio L. Eizirik, Raghavendra G. Mirmira

Research output: Contribution to journalReview article

7 Scopus citations


Recent work on the pathogenesis of type 1 diabetes has led to an evolving recognition of the heterogeneity of this disease, both with regards to clinical phenotype and responses to therapies to prevent or revert diabetes. This heterogeneity not only limits efforts to accurately predict clinical disease but also is reflected in differing responses to immunomodulatory therapeutics. Thus, there is a need for robust biomarkers of beta cell health, which could provide insight into pathophysiological differences in disease course, improve disease prediction, increase the understanding of therapeutic responses to immunomodulatory interventions and identify individuals most likely to benefit from these therapies. In this review, we outline current literature, limitations and future directions for promising circulating markers of beta cell stress and death in type 1 diabetes, including markers indicating abnormal prohormone processing, circulating RNAs and circulating DNAs.

Original languageEnglish (US)
Pages (from-to)2259-2265
Number of pages7
Issue number11
StatePublished - Nov 1 2018


  • Biomarker
  • Diabetes mellitus
  • Pancreatic beta cells
  • Pancreatic islets
  • Review
  • Type 1 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Biomarkers of islet beta cell stress and death in type 1 diabetes'. Together they form a unique fingerprint.

Cite this